Area of research
Pharmacology · Surgery
Research interest
Research focused on Aryl hydrocarbon receptor and Genome-wide association study, with related work in Vascular smooth muscle, Epigenetics, RNA. Notable publications include 'Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci', 'Coronary Heart Disease-Associated Variation in TCF21 Disrupts a miR-224 Binding Site and miRNA-Mediated Regulation', and 'Abstract 152: Osteochondrogenic Transcription Factor SOX9 Regulates The Epigenetic Mechanisms Of Atherosclerosis And Intimal Calcification'.
Abstract 152: Osteochondrogenic Transcription Factor SOX9 Regulates The Epigenetic Mechanisms Of Atherosclerosis And Intimal Calcification
Abstract 3074: RNA Editing Enzyme <i>ADAR1</i> In Vascular Smooth Muscle Controls Vascular Integrity And Progression Of Atherosclerosis
Abstract 2077: The Epigenetic Regulator <i>PRDM16</i> Controls Smooth Muscle Phenotypic Modulation And Atherosclerosis Risk
Abstract 703: Dioxin-induced Smooth Muscle Cell Phenotypic Modulation And Atherosclerosis Worsens In The Absence Of AHR
Abstract 12901: ADAR1 RNA Editing in Vascular Smooth Muscle Maintains Vascular Integrity, Regulates Cell State Transition, and is a Novel Mechanism of Coronary Artery Disease Risk
Abstract 222: The Molecular Mechanisms Of Coronary Artery Disease Risk At The <i>Pdgfd</i> Locus
Abstract 532: Dioxin Modifies The Transcriptomic And Epigenetic Landscape Of Smooth Muscle Cells Leading To Adverse Remodeling Of Atherosclerosis
Abstract 220: <i>Smad3</i> Regulates Smooth Muscle Cell Fate And Governs Adverse Remodeling And Calcification Of Atherosclerotic Plaque
Abstract 107: A Human Arterial Cell Atlas
Abstract 9564: Zeb2 Shapes the Epigenetic Landscape of Atherosclerosis and Modulates the Risk of Myocardial Infarction
Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci
Coronary Heart Disease-Associated Variation in TCF21 Disrupts a miR-224 Binding Site and miRNA-Mediated Regulation